Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03996226 · ClinicalTrials.gov registry record · Phase 1
A Food-Effect Study of E7386 in Healthy Participants
A Phase 1 study of Food Effect in Healthy Participants, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03996226 is a Phase 1 study of Food Effect in Healthy Participants that has completed, run by Eisai. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03996226, a Phase 1 study of Food Effect in Healthy Participants, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine the effect of food in healthy participants on the bioavailability of E7386 following single dose administration with and without a meal.
Conditions Studied
Interventions
- DRUG E7386
Study Locations (1)
Texas
- PPD - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-06-07 |
| Est. Completion | 2019-10-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03996226
The ClinicalTrials.gov registry entry for NCT03996226 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Food Effect in Healthy Participants appearing as the primary indexed condition, and to 1 intervention - of which E7386 is the first listed.
NCT03996226 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03996226 about?
NCT03996226 is a clinical study titled "A Food-Effect Study of E7386 in Healthy Participants". The primary objective of this study is to determine the effect of food in healthy participants on the bioavailability of E7386 following single dose administration with and without a meal.
What is the current status of trial NCT03996226?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2019-06-07. Estimated completion is 2019-10-29.
What conditions does trial NCT03996226 study?
This clinical trial studies the following conditions: Food Effect in Healthy Participants.
What interventions are being tested in trial NCT03996226?
The interventions under investigation include: E7386 (DRUG).
Who is sponsoring clinical trial NCT03996226?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03996226 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.